ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,159 | +1643.1% | 282,478 | +624.6% | 0.00% | – |
| Q4 2022 | $20,662 | -55.1% | 38,984 | -38.3% | 0.00% | – |
| Q3 2022 | $46,000 | -64.6% | 63,215 | -0.2% | 0.00% | – |
| Q1 2022 | $130,000 | -54.7% | 63,346 | -36.5% | 0.00% | – |
| Q4 2021 | $287,000 | -60.2% | 99,705 | -41.4% | 0.00% | – |
| Q3 2021 | $721,000 | +41.1% | 170,184 | +76.5% | 0.00% | – |
| Q2 2021 | $511,000 | -36.9% | 96,399 | -44.6% | 0.00% | – |
| Q1 2021 | $810,000 | +73.8% | 174,131 | +26.0% | 0.00% | – |
| Q2 2020 | $466,000 | +441.9% | 138,145 | +1116.9% | 0.00% | – |
| Q3 2019 | $86,000 | -64.8% | 11,352 | -37.0% | 0.00% | – |
| Q2 2019 | $244,000 | +577.8% | 18,005 | +46.8% | 0.00% | – |
| Q4 2018 | $36,000 | -87.6% | 12,267 | -65.5% | 0.00% | -100.0% |
| Q3 2018 | $290,000 | +21.3% | 35,555 | +44.6% | 0.00% | 0.0% |
| Q2 2018 | $239,000 | – | 24,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |